KR100822835B1 - Plant extracts and cosmetic compositions for improvement of scalp and hair - Google Patents
Plant extracts and cosmetic compositions for improvement of scalp and hair Download PDFInfo
- Publication number
- KR100822835B1 KR100822835B1 KR1020070106302A KR20070106302A KR100822835B1 KR 100822835 B1 KR100822835 B1 KR 100822835B1 KR 1020070106302 A KR1020070106302 A KR 1020070106302A KR 20070106302 A KR20070106302 A KR 20070106302A KR 100822835 B1 KR100822835 B1 KR 100822835B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- hair
- scalp
- effect
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 210000004209 hair Anatomy 0.000 title claims abstract description 96
- 210000004761 scalp Anatomy 0.000 title claims abstract description 68
- 239000002537 cosmetic Substances 0.000 title claims abstract description 32
- 230000006872 improvement Effects 0.000 title description 39
- 239000000419 plant extract Substances 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 9
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 8
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 7
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 7
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 7
- 240000002045 Guettarda speciosa Species 0.000 claims abstract description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 5
- 239000006071 cream Substances 0.000 claims abstract description 5
- 235000011187 glycerol Nutrition 0.000 claims abstract description 5
- 239000006210 lotion Substances 0.000 claims abstract description 5
- 239000002453 shampoo Substances 0.000 claims abstract description 5
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000411851 herbal medicine Species 0.000 claims description 46
- 241000208340 Araliaceae Species 0.000 claims description 11
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 6
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 6
- 240000001260 Tropaeolum majus Species 0.000 claims description 5
- 235000004424 Tropaeolum majus Nutrition 0.000 claims description 5
- 235000002789 Panax ginseng Nutrition 0.000 claims description 3
- 239000010865 sewage Substances 0.000 claims description 3
- 244000000231 Sesamum indicum Species 0.000 claims description 2
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 240000007890 Leonurus cardiaca Species 0.000 claims 2
- 235000009508 confectionery Nutrition 0.000 claims 2
- 240000007124 Brassica oleracea Species 0.000 claims 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 75
- 230000003779 hair growth Effects 0.000 abstract description 39
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 23
- 239000003814 drug Substances 0.000 abstract description 19
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 13
- 201000004384 Alopecia Diseases 0.000 abstract description 9
- 230000003676 hair loss Effects 0.000 abstract description 9
- 230000003020 moisturizing effect Effects 0.000 abstract description 9
- 206010040880 Skin irritation Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 7
- 208000024963 hair loss Diseases 0.000 abstract description 7
- 231100000475 skin irritation Toxicity 0.000 abstract description 7
- 230000036556 skin irritation Effects 0.000 abstract description 7
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 4
- 230000003405 preventing effect Effects 0.000 abstract description 3
- 240000007185 Albizia julibrissin Species 0.000 abstract description 2
- 235000011468 Albizia julibrissin Nutrition 0.000 abstract description 2
- 240000005250 Chrysanthemum indicum Species 0.000 abstract description 2
- 235000018959 Chrysanthemum indicum Nutrition 0.000 abstract description 2
- 241000533367 Cnidium officinale Species 0.000 abstract description 2
- 244000286838 Eclipta prostrata Species 0.000 abstract description 2
- 244000226566 Psoralea corylifolia Species 0.000 abstract description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract description 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001034916 Corydalis turtschaninovii Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 240000002817 Leonurus sibiricus Species 0.000 abstract 1
- 235000002434 Leonurus sibiricus Nutrition 0.000 abstract 1
- 241000201320 Ligustrum japonicum Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001618264 Rubus coreanus Species 0.000 abstract 1
- 241000246044 Sophora flavescens Species 0.000 abstract 1
- 241000218636 Thuja Species 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 55
- 238000009472 formulation Methods 0.000 description 34
- 239000012676 herbal extract Substances 0.000 description 23
- 238000011156 evaluation Methods 0.000 description 22
- 238000012360 testing method Methods 0.000 description 18
- 230000017531 blood circulation Effects 0.000 description 14
- 239000002075 main ingredient Substances 0.000 description 14
- 210000004969 inflammatory cell Anatomy 0.000 description 13
- -1 2-methylpropanoyl Chemical group 0.000 description 12
- 210000002268 wool Anatomy 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 10
- 208000001840 Dandruff Diseases 0.000 description 9
- 102000003820 Lipoxygenases Human genes 0.000 description 9
- 108090000128 Lipoxygenases Proteins 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 210000000442 hair follicle cell Anatomy 0.000 description 8
- 230000036961 partial effect Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000008216 herbs Nutrition 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000003658 preventing hair loss Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 241000207925 Leonurus Species 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 210000003780 hair follicle Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000003664 tensile strength of the hair Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- OAUREGNZECGNQS-IBGZPJMESA-N (2s)-7-hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one Chemical compound C1([C@@H]2CC(=O)C=3C=C(C(=CC=3O2)O)CC=C(C)C)=CC=C(O)C=C1 OAUREGNZECGNQS-IBGZPJMESA-N 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 3
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000241838 Lycium barbarum Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000009023 Myrrhis odorata Species 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- MPIBOQKDJNGGSK-BPNCWPANSA-N (1ar,4as,8as)-4a,8,8-trimethyl-1a,5,6,7-tetrahydro-1h-cyclopropa[j]naphthalen-2-one Chemical compound C1=CC(=O)[C@@H]2C[C@@]22C(C)(C)CCC[C@]21C MPIBOQKDJNGGSK-BPNCWPANSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- IGKWMHUOBKCUQU-USJZOSNVSA-N Aceritannin Natural products O[C@@H]1[C@@H](O)[C@H](COC(=O)c2cc(O)c(O)c(O)c2)OC[C@@H]1OC(=O)c3cc(O)c(O)c(O)c3 IGKWMHUOBKCUQU-USJZOSNVSA-N 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- MEGPURSNXMUDAE-UHFFFAOYSA-N Scopoline Natural products C1C(O2)CC3N(C)C1C2C3O MEGPURSNXMUDAE-UHFFFAOYSA-N 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- OAUREGNZECGNQS-UHFFFAOYSA-N corylifolin Natural products O1C=2C=C(O)C(CC=C(C)C)=CC=2C(=O)CC1C1=CC=C(O)C=C1 OAUREGNZECGNQS-UHFFFAOYSA-N 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000003700 hair damage Effects 0.000 description 2
- 230000003659 hair regrowth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000000774 hypoallergenic effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- YFDKIHAZVQFLRC-UHFFFAOYSA-N methuyl tanshinonate Chemical compound C1=2OC=C(C)C=2C(=O)C(=O)C2=C1C=CC1=C2CCCC1(C)C(=O)OC YFDKIHAZVQFLRC-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- MEGPURSNXMUDAE-RLMOJYMMSA-N scopoline Chemical compound C([C@H](O1)C2)[C@@H]3N(C)[C@H]2[C@H]1[C@H]3O MEGPURSNXMUDAE-RLMOJYMMSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- RGSHXVKKSKRNJG-YEWYEPQMSA-N (2r,3s,4s,6ar,6bs,8as,11r,12r,12as,14br)-3-[(2r,3r,4s,6ar,6bs,8as,11r,12r,12as,14br)-2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecah Chemical compound O=C([C@]12CC[C@@H](C)[C@@](C)(O)[C@H]1C1=CCC3[C@@]4(C)C[C@@H](O)[C@H]([C@](C4CC[C@@]3(C)[C@]1(C)CC2)(CO)C(O)=O)OC(=O)[C@]1(C)[C@@H](O)[C@H](O)C[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC21)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RGSHXVKKSKRNJG-YEWYEPQMSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- MIJYXULNPSFWEK-LGSDIRQTSA-N (4as,6as,6br,10r,12ar)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C[C@@H](O)C(C)(C)C2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)CC5C4=CCC3[C@]21C MIJYXULNPSFWEK-LGSDIRQTSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- HARGZZNYNSYSGJ-UHFFFAOYSA-N 1,2 dihydrotanshinquinone Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)CO1 HARGZZNYNSYSGJ-UHFFFAOYSA-N 0.000 description 1
- QDFFAXSMLUUJSG-UHFFFAOYSA-N 1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2 QDFFAXSMLUUJSG-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N 12-hydroxylauric acid Chemical compound OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- UGAGPNKCDRTDHP-UHFFFAOYSA-N 16-hydroxyhexadecanoic acid Chemical compound OCCCCCCCCCCCCCCCC(O)=O UGAGPNKCDRTDHP-UHFFFAOYSA-N 0.000 description 1
- WKKBYJLXSKPKSC-JVJIQXRHSA-N 19alpha-hydroxyasiatic acid-28-O-beta-D-glucopyrannoside Chemical compound O=C([C@]12CC[C@H]([C@@]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)(C)O)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WKKBYJLXSKPKSC-JVJIQXRHSA-N 0.000 description 1
- GLVOOJKVWKZSGR-UHFFFAOYSA-N 3'-Angloyl-(S)-Hamaudol Natural products CC=C(C)/C(=O)OC1Cc2c(O)c3C(=O)C=C(C)Oc3cc2OC1(C)C GLVOOJKVWKZSGR-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- FMIMFCRXYXVFTA-UHFFFAOYSA-N 3-Oxo-12-oleanen-28-oic acid Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C FMIMFCRXYXVFTA-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- CFNMUZCFSDMZPQ-GHXNOFRVSA-N 7-[(z)-3-methyl-4-(4-methyl-5-oxo-2h-furan-2-yl)but-2-enoxy]chromen-2-one Chemical compound C=1C=C2C=CC(=O)OC2=CC=1OC/C=C(/C)CC1OC(=O)C(C)=C1 CFNMUZCFSDMZPQ-GHXNOFRVSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- CFKXWTNHIJAFNL-UHFFFAOYSA-N Acacic acid Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C CFKXWTNHIJAFNL-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- NOHMTCLUYAVQEY-YLOHOTJZSA-N Albigenic acid Chemical compound C1C[C@H](O)C(C)(C)C2CC[C@@]3(C)[C@]4(C)C[C@@H](O)[C@@]5(C(O)=O)CCC(C)(C)CC5=C4CCC3[C@]21C NOHMTCLUYAVQEY-YLOHOTJZSA-N 0.000 description 1
- NOHMTCLUYAVQEY-UHFFFAOYSA-N Albigenic acid Natural products CC1(C)CCC2(C(O)CC3(C)C(=C2C1)CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C(=O)O NOHMTCLUYAVQEY-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 1
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 1
- HARGZZNYNSYSGJ-JTQLQIEISA-N Dihydrotanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2[C@@H](C)CO1 HARGZZNYNSYSGJ-JTQLQIEISA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- YKOPWPOFWMYZJZ-FMMUPTMQSA-N Echinocystic acid Natural products C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)C[C@H](O)[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C YKOPWPOFWMYZJZ-FMMUPTMQSA-N 0.000 description 1
- YKOPWPOFWMYZJZ-UHFFFAOYSA-N Echinocystsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C YKOPWPOFWMYZJZ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KYFBXCHUXFKMGQ-IBGZPJMESA-N Isobavachin Chemical compound C1([C@@H]2CC(=O)C=3C=CC(O)=C(C=3O2)CC=C(C)C)=CC=C(O)C=C1 KYFBXCHUXFKMGQ-IBGZPJMESA-N 0.000 description 1
- LMDXLPTZCSMMDJ-UHFFFAOYSA-N Isobavachin Natural products O1C=2C(CC=C(C)C)=C(O)C=CC=2CCC1C1=CC=C(O)C=C1 LMDXLPTZCSMMDJ-UHFFFAOYSA-N 0.000 description 1
- GZYFIMLSHBLMKF-REOHCLBHSA-N L-Albizziine Chemical compound OC(=O)[C@@H](N)CNC(N)=O GZYFIMLSHBLMKF-REOHCLBHSA-N 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- VELYAQRXBJLJAK-MJSCJBMMSA-N Leonuridine Chemical compound C12C(C)(O)CC(O)C2C=COC1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VELYAQRXBJLJAK-MJSCJBMMSA-N 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102100030417 Matrilysin Human genes 0.000 description 1
- 108090000855 Matrilysin Proteins 0.000 description 1
- NLSTZAFFNDSJGQ-UHFFFAOYSA-N Matrin Natural products O=C1CCCN2CC3CCNC4CCCC(C34)C12 NLSTZAFFNDSJGQ-UHFFFAOYSA-N 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- RMCRQBAILCLJGU-UHFFFAOYSA-N Neoponcirin Natural products C1=CC(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 RMCRQBAILCLJGU-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 1
- 229930030856 Psoralidin Natural products 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- VQYBAEAOOJBSTR-QHSBEEBCSA-N Sophoranol Chemical compound C([C@@H]12)CCC(=O)N1C[C@@]1(O)[C@H]3[C@@H]2CCCN3CCC1 VQYBAEAOOJBSTR-QHSBEEBCSA-N 0.000 description 1
- VQYBAEAOOJBSTR-AYRXBEOTSA-N Sophoranol Natural products O=C1N2[C@H]([C@@H]3[C@@H]4[C@](O)(C2)CCCN4CCC3)CCC1 VQYBAEAOOJBSTR-AYRXBEOTSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- YXSQSVWHKZZWDD-UHFFFAOYSA-N Suavissimoside R1 Natural products C1CC(C2(CCC3C(C)(C(O)C(O)CC3(C)C2CC=2)C(O)=O)C)(C)C=2C2C(O)(C)C(C)CCC21C(=O)OC1OC(CO)C(O)C(O)C1O YXSQSVWHKZZWDD-UHFFFAOYSA-N 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- GLVOOJKVWKZSGR-DIEDAUMRSA-N [(3s)-5-hydroxy-2,2,8-trimethyl-6-oxo-3,4-dihydropyrano[3,2-g]chromen-3-yl] (z)-2-methylbut-2-enoate Chemical compound C1=C2OC(C)=CC(=O)C2=C(O)C2=C1OC(C)(C)[C@@H](OC(=O)C(\C)=C/C)C2 GLVOOJKVWKZSGR-DIEDAUMRSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- CFKXWTNHIJAFNL-OOURDANISA-N acacic acid Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC=C2[C@@H]3CC(C)(C)[C@@H](O)C[C@]3(C(O)=O)[C@H](O)C[C@]21C CFKXWTNHIJAFNL-OOURDANISA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- BZXULBWGROURAF-UHFFFAOYSA-N alpha-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C BZXULBWGROURAF-UHFFFAOYSA-N 0.000 description 1
- 229930014345 anabasine Natural products 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 229940117895 bakuchiol Drugs 0.000 description 1
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 description 1
- VOCGSQHKPZSIKB-UHFFFAOYSA-N bavachinin A Natural products C1C(=O)C=2C=C(CC=C(C)C)C(OC)=CC=2OC1C1=CC=C(O)C=C1 VOCGSQHKPZSIKB-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 1
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- KXNYCALHDXGJSF-UHFFFAOYSA-N dihydroisotanshinone I Natural products CC1=CC=CC2=C(C(C=3OCC(C=3C3=O)C)=O)C3=CC=C21 KXNYCALHDXGJSF-UHFFFAOYSA-N 0.000 description 1
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- UKIOTQZYKUPESG-UHFFFAOYSA-N dl-Tetrahydrocoptisine Natural products C1=C2C(C)C3C4=CC(OCO5)=C5C=C4CCN3CC2=C2OCOC2=C1 UKIOTQZYKUPESG-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XDROKJSWHURZGO-UHFFFAOYSA-N isopsoralen Natural products C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229930191967 kalopanaxsaponin Natural products 0.000 description 1
- WUVYENIUARJBNM-JLNYLFASSA-N lehmanine Chemical compound C1CC[C@H]2CN3C(=O)CC=C[C@@H]3[C@@H]3[C@H]2N1CCC3 WUVYENIUARJBNM-JLNYLFASSA-N 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- WAFDWKYNSTVECG-UHFFFAOYSA-L magnesium;3-[(4-nitrophenyl)methoxy]-3-oxopropanoate Chemical compound [Mg+2].[O-]C(=O)CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1.[O-]C(=O)CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 WAFDWKYNSTVECG-UHFFFAOYSA-L 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- MCHWKJRTMPIHRA-UHFFFAOYSA-N n-(pyrrolidin-2-ylmethyl)aniline Chemical compound C1CCNC1CNC1=CC=CC=C1 MCHWKJRTMPIHRA-UHFFFAOYSA-N 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- WKKBYJLXSKPKSC-UHFFFAOYSA-N niga-ichigoside F2 Natural products C1CC(C2(CCC3C(C)(CO)C(O)C(O)CC3(C)C2CC=2)C)(C)C=2C2C(O)(C)C(C)CCC21C(=O)OC1OC(CO)C(O)C(O)C1O WKKBYJLXSKPKSC-UHFFFAOYSA-N 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- MXEMKMNFLXVQBW-UHFFFAOYSA-N oleanoic acid Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MXEMKMNFLXVQBW-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940079988 potassium cocoyl glycinate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 1
- 229940032044 quaternium-18 Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 231100001068 severe skin irritation Toxicity 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- YHWNASRGLKJRJJ-UHFFFAOYSA-N sophoraflavanone B Natural products C1C(=O)C2=C(O)C(CC=C(C)C)=C(O)C=C2OC1C1=CC=C(O)C=C1 YHWNASRGLKJRJJ-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-BHPKHCPMSA-N sophoridine Chemical compound C1CC[C@@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-BHPKHCPMSA-N 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000003478 temporal lobe Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229930007110 thujone Natural products 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 두피 및 모발 개선을 위한 생약재 추출물과 이를 이용한 두피 및 모발 개선 조성물에 관한 것으로서, 보다 상세하게는 발모 및 탈모방지의 효과를 갖는 약재, 흰머리 방지의 효과를 갖는 약재, 피부진정 효과를 갖는 약재, 혈액순환을 개선해주는 약재 등을 포함하는 생약재 추출물과 이를 이용한 저자극성 두피 및 모발 개선용 화장료 조성물에 관한 것이다.The present invention relates to an herbal extract for improving the scalp and hair and scalp and hair improving composition using the same, more specifically, a medicine having the effect of preventing hair loss and hair loss, a medicine having the effect of preventing baldness, having a soothing effect It relates to herbal medicine extracts, including herbal medicines, such as to improve the blood circulation and hypoallergenic scalp and hair improvement cosmetic composition using the same.
일반적으로 탈모의 원인은 남성호르몬에 의한 작용, 혈액순환의 불량으로 인한 혈류량 감소로 인한 모근부의 신진대사 기능저하, 영양부족, 약물에 의한 부작용, 비듬균이나 세균에 의한 두피 손상, 유전적 요인 등이 알려져 있다. 또한, 과도한 샴푸, 건조, 헤어스타일링 등으로 인한 두피 및 모발의 자극과 화학 세정성분에 의한 두피의 천연 보습성분이 제거됨으로써 두피 및 모발이 손상을 받는 것으로 알려져 있다. 특히, 최근에는 사회 환경 등의 변화로 인한 스트레스의 과도한 증가로 탈모 및 모발 손상 증상으로 고민하는 인구가 늘어나는 추세이고, 연령대 및 성별의 제한 및 경계 또한 넓어지고 있는 상황이다.Generally, the causes of hair loss include the effects of male hormones, decreased metabolic function in the hair roots due to poor blood circulation, malnutrition, side effects from drugs, damage to the scalp by dandruff or bacteria, and genetic factors. Known. In addition, the scalp and hair due to excessive shampoo, drying, hair styling and the like and the natural moisturizing component of the scalp by the chemical cleansing ingredients are removed to damage the scalp and hair. In particular, in recent years, a growing number of people who suffer from hair loss and hair damage due to excessive stress due to changes in the social environment, etc., and the age and gender restrictions and boundaries are also expanding.
따라서 탈모예방을 비롯하여 두피 및 모발의 상태를 개선할 수 있는 소재 및 성분에 대한 연구가 활발히 진행돼 왔으며, 이러한 소재 및 성분으로서 대한민국 등록특허 제10-0038819호, 제10-0026222호, 제10-0002207호, 제10-0046064호 등에서 소개된 바와 같이 항남성호르몬제, 항지루제, 각질용해제 및 제거제, 비듬균살균제 및 아미노산류, 비타민류 등이 사용되어 왔다. 하지만 이와 같은 기존의 소재 및 성분들은 탈모방지 및 모발개선 효과가 우수하지 못하고, 안전성 및 피부자극에 대한 문제점으로 그 함량에 대한 제한이 있는 것으로 지적되고 있다.Therefore, researches on materials and ingredients that can improve the condition of the scalp and hair, including prevention of hair loss, have been actively conducted, and as such materials and ingredients, Korean Patent Nos. 10-0038819, 10-0026222, and 10- As introduced in 0002207, 10-0046064, etc., anti-male hormones, anti-seborrheic agents, keratin-dissolving agents and removing agents, dandruff disinfectants and amino acids, vitamins, and the like have been used. However, these existing materials and ingredients are not excellent in hair loss prevention and hair improvement effect, it is pointed out that there is a limit to the content as a problem for safety and skin irritation.
상기 화학적 제제와 같은 직접적인 약리학적 처방들과 달리 한의학에서는 전통적으로 두피 및 모발 개선과 관련하여 피부와 연관된 간장과 신장 기능의 강화, 보혈 및 혈액순환의 개선에 따른 두피 내의 혈류량 증가 및 순환기능의 개선을 가져다줄 수 있는 생약처방을 통한 간접적인 치료와 예방에 보다 중점을 두었다.Unlike direct pharmacological prescriptions such as chemicals, traditional Chinese medicine has traditionally been associated with the improvement of scalp and hair, and the enhancement of hepatic and renal function associated with the skin, increased blood flow and blood circulation in the scalp due to improved blood and blood circulation. The focus has been on indirect treatment and prevention through herbal remedies that can lead to the development of medicinal products.
최근에, 과학적 평가방법이 연구되면서 대한민국 등록특허 제10-0298647호, 제10-0524291호, 제10-0534483호, 제10-0509910호 등과 같이 생약재 추출물의 발모효과, 양모효과, 항균효과, 피부진정 효과 등에 대하여 과학적 검증이 이루지면서 상기 화학적 제제의 단점을 보완할 수 있는 두피 및 모발 개선 생약재 추출물이 다양하게 개발되고 있다. 하지만 아직까지 발모 및 탈모방지 효과, 육모 및 양모 효과, 가려움 방지 효과, 보습효과, 갈라짐 방지효과 등 여러 가지 효과가 모두 탁월하고 안전성 측면에서 저자극성인 두피 및 모발용 화장료 조성물에 대한 필요성은 꾸준히 제기되고 있다.Recently, as scientific evaluation methods have been studied, hair growth effect, wool effect, antibacterial effect, skin of herbal extracts such as Korean Patent Registration Nos. 10-0298647, 10-0524291, 10-0534483, 10-0509910, etc. With scientific verification of soothing effects, various scalp and hair improvement herbal extracts that can compensate for the shortcomings of the chemical preparations have been developed. However, the need for scalp and hair cosmetic compositions that are all excellent and hypoallergenic in terms of safety are still steadily being raised, such as anti-hair and hair loss effect, hair growth and wool effect, anti-itch effect, moisturizing effect, and crack prevention effect. have.
본 발명에서는 기존의 두피 및 모발 개선 조성물의 단점인 피부자극, 천연보습성분의 제거로 인한 두피 및 모발 손상을 초래하지 않으면서 우수한 발모 및 탈모방지 효과, 육모 및 양모 효과, 비듬균에 대한 항균효과, 가려움 방지효과, 보습효과, 모발의 유연성 향상효과 및 갈라짐 방지효과를 갖는 생약재 추출물과 이를 함유하는 조성물을 제공함에 본 발명의 목적이 있다.In the present invention, excellent hair growth and hair loss prevention effect, hair growth and wool effect, antibacterial effect against dandruff, without causing skin irritation, scalp and hair damage caused by the removal of natural moisturizing ingredients, which are disadvantages of existing scalp and hair improvement composition, It is an object of the present invention to provide an herbal extract having an anti-itch effect, moisturizing effect, hair flexibility improvement effect and anti-cracking effect and a composition containing the same.
전술한 본 발명의 목적을 달성하기 위해, 본 발명은 당귀, 보골지, 측백엽, 한련초, 구기자, 복분자, 상백피, 숙지황, 여정실, 적하수오, 흑지마, 고삼, 백지, 익모초, 단삼, 도인, 몰약, 감국, 유향, 인삼, 천궁, 합환피 및 현호색의 혼합 생약재 추출물을 포함하는 것을 특징으로 하는 두피 및 모발용 조성물을 제공한다.In order to achieve the above object of the present invention, the present invention is Angelica, Bogolji, baekbaekye, nasturtium, wolfberry, Bokbunja, Sangbaekpi, Sukjiwang, Jojeongsil, Drip Shou, Black Jim, Gosam, White Paper, Motherwort, Dansam, Doin, Myrrh Provides a composition for scalp and hair, characterized in that it comprises a mixed herbal extract of gamguk, frankincense, ginseng, cheongung, haphwanpi and Hyunho color.
보다 바람직하게, 본 발명은 상기 조성물에 있어 혼합 생약재가 당귀, 보골지, 측백엽 및 한련초를 각각 1 내지 5 중량부; 구기자, 복분자, 상백피, 숙지황, 여정실, 적하수오 및 흑지마를 각각 0.5 내지 6 중량부; 고삼, 백지 및 익모초를 각각 1 내지 20 중량부; 및 단삼, 도인, 몰약, 감국, 유향, 인삼, 천궁, 합환피 및 현호색을 각각 0.5 내지 4 중량부 함유하는 것을 특징으로 하는 두피 및 모발용 조성물을 제공한다.More preferably, the mixed herbal medicine in the composition is 1 to 5 parts by weight, respectively, Angelica, golgol, baekryeop and nasturtium; 0.5 to 6 parts by weight of Gugija, Bokbunja, Sangbaekpi, Sukjihwang, Journey, Red Sewage, and Black Horse; 1 to 20 parts by weight of red ginseng, white paper and motherwort, respectively; And it provides a composition for scalp and hair, characterized in that it contains 0.5 to 4 parts by weight, respectively, Dansam, Doin, myrrh, persimmon soup, frankincense, ginseng, Cheongung, Haphwanpi and Hyunho colors.
본 발명에 따른 화장료 조성물은 발모 및 탈모방지 효과, 양모효과, 항균효과, 가려움 방지효과, 및 두피 및 모발의 보습효과가 우수하며 피부자극과 같은 부 작용을 유발하지 않는다.The cosmetic composition according to the present invention is excellent in hair growth and hair loss preventing effect, wool effect, antibacterial effect, anti-itch effect, and moisturizing effect of the scalp and hair and does not cause side effects such as skin irritation.
이하 본 발명에 따른 두피 및 모발 개선용 생약재 추출물 및 이를 이용한 화장료 조성물에 대해 보다 상세히 설명한다.Hereinafter, the herbal extract for improving scalp and hair and the cosmetic composition using the same according to the present invention will be described in detail.
먼저, 본 발명에 따른 화장료 조성물이 포함하는 생약재 추출물들의 각 성분에 대해 보다 구체적으로 설명한다.First, the components of the herbal extracts contained in the cosmetic composition according to the present invention will be described in more detail.
본 발명에 따른 생약재 중 당귀(Angelica gigas Nakai)는 뿌리와 전초에 쿠마린이 많이 포함되어 있다. 쿠마린의 주성분은 데쿠르신, 데쿠르시놀, 오스톨, 움벨리프레닌 등이 알려졌다. 뿌리는 또한 정유, 수지 등을 주요성분으로 포함하며 혈액순환 개선, 항균작용, 항염작용 등이 우수한 약재로 알려져 있다. Angelica gigas Nakai of the herbal medicine according to the present invention contains a lot of coumarin in the root and outpost. The main constituents of coumarin are known as decursin, decursinol, ostol, umbellininine and the like. Root also contains essential oils, resins, etc., and is known as an excellent medicine for improving blood circulation, antibacterial action and anti-inflammatory action.
본 발명에 따른 생약재 중 보골지(Psoralea corylifolia Linne)는 수지, 정유, bakuchiol, psoralen, angelicin, bavachin, isobavachin 등이 함유되어 있고, 껍질에는 psoralidin, corylifolin 등을 주요성분으로 포함하며 신장 기능을 개선하며 소염작용, 진통작용이 우수한 약재로 알려져 있다.Among the herbal medicines according to the present invention, golgol ( Psoralea corylifolia Linne) contains a resin, essential oil, bakuchiol, psoralen, angelicin, bavachin, isobavachin, etc., the shell contains psoralidin, corylifolin as the main ingredients and improves kidney function It is known as an excellent anti-inflammatory and analgesic medicine.
본 발명에 따른 생약재 중 측백엽(Biota orientalis Endllcher)은 juniperic acid, thujone, mayurone, sabinic acid 등을 주요성분으로 포함하며 소염작용, 항균작용 등이 우수한 약재로 알려져 있다.Cheukbaekyeop (Biota orientalis Endllcher) of saengyakjae according to the invention comprises a juniperic acid, thujone, mayurone, sabinic acid, etc. as a main component, and there is known to be excellent medicines such as anti-inflammatory action, antibacterial action.
본 발명에 따른 생약재 중 한련초(Eclipta prostrata Linne)는 nicotine, anabasine, acacetin-7-O-rutinoside, 3-O-angeloylhamaudol, 2-methylpropanoyl, kalopanax saponin, acertannin, vitamin A, thiophene 등을 주요성분으로 포함하며 지혈효과 등이 우수한 약재로 알려져 있다.Among the herbal medicines according to the present invention, Eclipta prostrata Linne includes nicotine, anabasine, acacetin-7-O-rutinoside, 3-O-angeloylhamaudol, 2-methylpropanoyl, kalopanax saponin, acertannin, vitamin A, thiophene, etc. It is known as an excellent hemostatic effect.
본 발명에 따른 생약재 중 구기자(Lycium chinense Miller)는 지방질, 단백질, 당질, 섬유질 및 카로티노이드인 제아크산틴, 18종의 아미노산, 다당류, 피살리엔, 스코폴레틴 등을 주요성분으로 포함하며 면역증강, 보혈작용, 청혈작용 및 피부진정 작용이 우수한 약재로 알려져 있다.Wolfberry ( Lycium) among herbal medicines according to the present invention chinense Miller) contains lipids, proteins, sugars, fibers and carotenoids, zeaxanthin, 18 amino acids, polysaccharides, pisalien, scopoline, etc. It is known as this excellent medicine.
본 발명에 따른 생약재 중 복분자(Rubus coreanus Miquel)는 coreanogenoic acid, coreanoside F1, nigaichigoside F1, suavissimoside R1, 정유, Saccharide, vitamin C 등을 주요성분으로 포함하며 해열작용, 강심작용, 이뇨작용 및 피부세포 손상을 예방하는 항산화작용이 우수한 약재로 알려져 있다.Bokbunja ( Rubus) among herbal medicines according to the present invention coreanus Miquel) contains coreanogenoic acid, coreanoside F1, nigaichigoside F1, suavissimoside R1, essential oils, Saccharide and vitamin C as main ingredients, and is known as an excellent anti-oxidant agent for antipyretic, cardiovascular, diuretic and skin cell damage have.
본 발명에 따른 생약재 중 상백피(Morus alba Linne)는 물베르린, 물베르로크로벤, 시클로물베르린 등과 쿠마린 유도체인 스코폴레틴, 움벨리페론, 트리테르페노이드인 아미린, 베툴린산 등을 주요성분으로 포함하며 진정작용, 진해작용, 항균작용, 항염작용, 항산화효과 등이 우수한 약재로 알려져 있다. Morus alba in herbal medicine according to the present invention alba Linne) contains umberrin, umberlobogen, cyclomulberin, and coumarin derivatives such as scopoline, umbeliferon, and triterpenoids such as amiline and betulinic acid. It is known as an excellent medicine for action, anti-inflammatory action, antioxidant effect.
본 발명에 따른 생약재 중 숙지황(Rehmannia glutinosa Liboschitz var . purpurea Makino)은 카탈폴, 레흐마닌 등의 이리도이드 배당체와 만니톨, 스타키오즈, 글루코스, 아미노산 등을 주요성분으로 포함하며 보혈작용 및 수렴작용이 우수하고 해독 및 피부진정 작용 등이 우수한 약재로 알려져 있다.Sukjiwang ( Rehmannia) among herbal medicines according to the present invention glutinosa Liboschitz var . purpurea Makino) contains iridoid glycosides such as catalpol and lehmanine, as well as mannitol, stakiose, glucose, and amino acids as its main ingredients. .
본 발명에 따른 생약재 중 여정실(Ligustrum lucidum Aiton)은 d-mannit, 올레아놀산, 올레산, 리놀레산 등을 주요성분으로 포함하며 간장과 신장을 보하고 모발을 검게 하며 항염증효과가 우수한 약재로 알려져 있다.Among the herbal medicines according to the present invention ( Ligustrum lucidum Aiton) contains d-mannit, oleanolic acid, oleic acid, linoleic acid and the like as the main ingredients to protect the liver and kidneys, black hair and is known as an excellent anti-inflammatory effect.
본 발명에 따른 생약재 중 적하수오(Polygonum multiflorum Thunberg)는 폴 리옥시프레그난 배당체를 함유하고 있으며, 시베리아코시드 D 배당체, 당, 녹말, 지방질 등을 주요성분으로 포함하며 보혈작용 등이 우수한 약재로 알려져 있다.Drip Sewage ( Polygonum) among herbal medicines according to the present invention multiflorum Thunberg) contains polyoxypregnan glycosides, contains Siberia coside D glycosides, sugars, starches, fats, etc. as main ingredients, and is known as an excellent medicinal herb.
본 발명에 따른 생약재 중 흑지마(Sesamum indicum Linne)는 올레산, 리놀레산, 팔미티산 등이 포함된 지방유를 주요성분으로 포함하며 간과 신장을 보하며 소염작용 및 모발을 검게 하는데 효과적인 약재로 알려져 있다.Among the herbal medicines according to the present invention, black jima ( Sesamum indicum Linne) contains fatty oils containing oleic acid, linoleic acid, palmitic acid, etc. as main ingredients, and is known as an effective medicine for anti-inflammatory action and blacking hair while protecting liver and kidney.
본 발명에 따른 생약재 중 고삼(Sophora angustifolia Siebold et Zuccarini)은 마트린, 옥시마트린, 소포라놀, 메틸시티진, 아나기린, 알로마트린, 아이소하이드로이카리틴, 노르-안하이드로이카리틴 등을 주요성분으로 포함하며 항염작용, 항진균작용, 항균 및 항알레르기 작용 등이 우수한 약재로 알려져 있다.Ginseng among herbal medicines according to the present inventionSophora angustifolia Siebold et Zuccarini) contains the main components of matrin, oxymatrine, sophoranol, methylcytizin, anagiline, allomatrine, isohydrokaritin, nor-anhydroikaritin, and anti-inflammatory, antifungal and antibacterial activity And it is known as an excellent drug for antiallergic action.
본 발명에 따른 생약재 중 백지(Angelica dahurica Bentham et Hooker)는 쿠마린 유도체로서 임페라토린, 펠로프테린, 크산토톡신, 비악안겔라신, 비악안겔리콜 및 정유 성분을 주요성분으로 포함하며 항염증 및 항알레르기 작용이 있어 피부진정 효과가 우수한 약재로 알려져 있다.White paper of herbal medicine according to the present invention dahurica Bentham et Hooker) is a coumarin derivative, which contains imperatorin, pelopterin, xanthotoxin, biaxangelacin, biaxangelicol, and essential oils as main ingredients, and has anti-inflammatory and anti-allergic properties. Known.
본 발명에 따른 생약재 중 익모초(Leonurus sibiricus Linne)는 leonurine, stachydrine, leonuridine, rutin, benzoic acid 등을 주요성분으로 포함하며 이뇨작용 및 혈액순환 개선효과가 우수한 약재로 알려져 있다.Motherwort ( Leonurus) among herbal medicines according to the present invention sibiricus Linne) contains leonurine, stachydrine, leonuridine, rutin, benzoic acid as main ingredients, and is known as an excellent drug for diuretic and blood circulation improvement.
본 발명에 따른 생약재 중 단삼(Salvia miltiorrhiza Bunge)은 tanshinone, dihydrotanshinone, cryptotanshinone, methyl tanshinonate, methylene tanshiquinone, beta-sitosterol 등을 주요성분으로 포함하며 혈액순환 개선, 어혈제거, 항염 및 항균 작용이 우수한 약재로 알려져 있다. Salvia miltiorrhiza Bunge of the herbal medicine according to the present invention contains tanshinone, dihydrotanshinone, cryptotanshinone, methyl tanshinonate, methylene tanshiquinone, beta-sitosterol as main ingredients, and improves blood circulation, removes blood, anti-inflammatory and antibacterial drugs. Known.
본 발명에 따른 생약재 중 도인(Prunus persica Batsch)은 아미그달린, 에물신, 올레인산, 리놀산, 팔미틴산, 시토스테롤 등을 주요성분으로 포함하며 혈액순환 개선, 항염작용, 피부보습 효과 등이 우수한 약재로 알려져 있다.Among the herbal medicines according to the present invention ( Prunus persica Batsch) contains amigdaline, emulsine, oleic acid, linoleic acid, palmitic acid and cytosterol as main ingredients and is known for its excellent blood circulation, anti-inflammatory and skin moisturizing effects.
본 발명에 따른 생약재 중 몰약(Commiphora molmol Engler)은 수지, 정유, 수교, terpene, sesquiterpene, cinnamic aldehyde 등을 주요성분으로 포함하며 혈액순환 개선, 소염작용, 살균 및 소독 작용이 우수한 약재로 알려져 있다.Myrrh of the herbal medicine according to the present invention ( Commyphora molmol Engler) contains resins, essential oils, handing, terpene, sesquiterpene, cinnamic aldehyde as the main ingredients, and is known as an excellent medicine for improving blood circulation, anti-inflammatory, sterilization and disinfection.
본 발명에 따른 생약재 중 감국(Chrysanthemum indicum Linne)은 보르네올, 보르닐아세테아트 디엘캄파, 테트라코잔, 헥사코잔 등의 정유성분과 아데닌, 콜린, 비타민 A, 비타민 B1 등을 주요성분으로 포함하며 혈압강하, 항염, 항균 작용 등이 우수한 약재로 알려져 있다. Chrysanthemum indicum Linne of the herbal medicine according to the present invention contains essential oils such as Borneol, Bornyl Aceteatel Campa, Tetracozan, Hexacozan and adenine, Choline, Vitamin A, Vitamin B1, etc. It is known as an excellent medicine for lowering blood pressure, anti-inflammatory, antibacterial action.
본 발명에 따른 생약재 중 유향(Boswellia carterii Birdwood)은 alpha-boswellic acid, beta-boswellic acid, olibanorescene, beta-pinene, dipentene 등을 주요성분으로 포함하며 소염작용 및 항염작용이 우수한 약재로 알려져 있다.Frankincense ( Boswellia carterii Birdwood) of the herbal medicine according to the present invention contains alpha-boswellic acid, beta-boswellic acid, olibanorescene, beta-pinene, dipentene as the main ingredients and is known as an excellent anti-inflammatory and anti-inflammatory drugs.
본 발명에 따른 생약재 중 인삼(Panax ginseng C. A. Meyer)은 사포닌 배당체로서 파낙사디올, 파낙사트리올, 베타-시스테롤, 올레아놀산 등과 파나센, 파낙시놀, 캠페롤, 트리폴림, 파나세노이드 및 비타민류, 니코틴산, 판토텐산, 폴산, 비오틴 등을 주요성분으로 포함하며 항스트레스, 혈압강하, 혈액순환 개선, 강장작용 등이 우수한 약재로 알려져 있다.Ginseng ( Panax) among herbal medicines according to the present invention ginseng CA Meyer) is a saponin glycoside, which is panaxanadiol, panaxanthol, beta-cysterol, oleanoic acid, and panacene, panaxinol, camphorol, tripolim, panacenoids and vitamins, nicotinic acid, pantothenic acid, folic acid, biotin Its main ingredients include antistress, lowering blood pressure, improving blood circulation, and tonic are known as excellent medicines.
본 발명에 따른 생약재 중 천궁(Cnidium officinale Makino)은 코니딜리드, 네오크니딜리드, 리구스틸리드, 크니디움산, 크니디움산에테르, 세다논산, 쿠마린, 만니톨 등을 주요성분으로 포함하며 혈액순환 개선작용, 및 항균작용이 우수한 약재로 알려져 있다.Cheongung of the herbal medicine according to the present invention (Cnidium officinale Makino) contains major ingredients such as condylide, neocidelide, ligustilide, knidium acid, knidium acid ether, sedananoic acid, coumarin, and mannitol, and has excellent blood circulation and antibacterial effects. Known.
본 발명에 따른 생약재 중 합환피(Albizzia julibrissin Durazzini)는 albigenic acid, echinocystic acid, acacic acid, quercetin, tirterpenoid, albizzin, 비타민 C, acertannin, julibroside, julibrin 등을 주요성분으로 포함하며 혈액순환 개선작용이 우수한 약재로 알려져 있다.The herbal medicine Albizzia julibrissin Durazzini according to the present invention contains albigenic acid, echinocystic acid, acacic acid, quercetin, tirterpenoid, albizzin, vitamin C, acertannin, julibroside, julibrin, etc. It is known as a medicine.
본 발명에 따른 생약재 중 현호색(Corylais ternata Nakai)은 코리달린, 알칼로이드, berberine, 1-canadine, protopine, 1-tetrahydrocoptisine 등을 주요성분으로 포함하며 어혈제거 및 혈액순환 개선작용, 진정작용 등이 우수한 약재로 알려져 있다.Corydalis ( Corylais) among herbal medicines according to the present invention ternata Nakai) contains corridin, alkaloid, berberine, 1-canadine, protopine, 1-tetrahydrocoptisine as main ingredients, and is known as an excellent medicine for removing blood, improving blood circulation, and sedating.
본 발명의 목적을 달성하기 위하여 제공되는 두피 및 모발 개선용 혼합 생약재 추출물은 (i) 20 내지 40℃에서 추출용매에 생약재 혼합물을 침지하여 추출하는 방법, (ⅱ) 60 내지 90℃에서 추출용매에 생약재 혼합물을 넣고 환류하여 추출하는 방법, (ⅲ) 20 내지 70℃에서 추출용매에 생약재 혼합물을 넣고 초음파를 조사하여 추출하는 방법, (ⅳ) 23종 각각의 생약재를 상기 (i), (ⅱ) 또는 (ⅲ)의 방법으로 개별 추출하고 각각의 추출물을 일정 비율에 따라 혼합하는 방법을 포함할 수 있으나, 이에 한정되는 것은 아니다.The mixed herbal medicine extract for improving scalp and hair provided to achieve the object of the present invention is (i) a method of extracting the medicinal herb mixture by dipping the extractant at 20 to 40 ° C, and (ii) the extractant at 60 to 90 ° C. A method of extracting the mixture of the herbal medicines by reflux, (iii) A method of extracting the herbal medicines mixture by extracting ultrasonic waves at 20 to 70 ℃ extraction solvent, (i) Each of the 23 kinds of herbal medicines (i), (ii) Or it may include a method of separately extracting by the method of (iii) and mixing each extract according to a certain ratio, but is not limited thereto.
상기 추출용매로는 물, 에탄올, 메탄올, 이소프로판올 등의 저급 알코올, 에틸아세테이트, 아세톤 등의 용매가 이용될 수 있으며, 또한 이외에도 글리세린, 부틸렌글라이콜, 프로필렌글라이콜 등의 다가알코올류도 추출용매로 포함될 수 있다. 다만, 본 발명에 따른 상기 생약재 혼합물의 추출용매로는 물, 에탄올 또는 이들의 혼합용매가 바람직하며, 이러한 추출용매를 추출용매와 생약재 혼합물의 총 중량 대비 90 내지 50 중량% 이용하여 추출하는 것이 더욱 바람직하다.As the extraction solvent, solvents such as lower alcohols such as water, ethanol, methanol and isopropanol, ethyl acetate and acetone may be used. In addition, polyhydric alcohols such as glycerin, butylene glycol and propylene glycol may also be extracted. It may be included as a solvent. However, as the extraction solvent of the herbal medicine mixture according to the present invention, water, ethanol or a mixed solvent thereof is preferable, and the extraction solvent is extracted by using 90 to 50% by weight relative to the total weight of the extraction solvent and the herbal medicine mixture. desirable.
본 발명의 두피 및 모발 조성물은 본 발명에 따른 효과를 발휘하는 성분인 생약재 추출물을 주성분으로 1 내지 80 중량%를 포함하는 것이 바람직하며, 10 내지 50 중량%를 포함하는 것이 보다 바람직하다.The scalp and hair composition of the present invention preferably contains 1 to 80% by weight, and more preferably 10 to 50% by weight of the herbal medicine extract that is an ingredient exhibiting the effect according to the present invention.
본 발명의 화장료 조성물은 두피 및 모발의 개선을 위한 상기 생약재 추출물 이외에 본 발명의 효과를 해치지 않는 범위 내에서 보습제, 증점제, 계면활성제, 유상기제, 방부제, 산화방지제, 알코올, 향료, pH 조절제, 천연추출물 등은 물론 두피 및 모발 개선효과를 배가시키기 위한 화학적 성분의 두피 및 모발개선 성분을 적당한 양으로 배합할 수 있다.The cosmetic composition of the present invention is a moisturizer, thickener, surfactant, emulsifier, preservative, antioxidant, alcohol, flavoring, pH adjusting agent, natural within the range that does not impair the effects of the present invention in addition to the herbal extract for the improvement of the scalp and hair. As well as extracts, the scalp and hair improvement components of the chemical components for doubling the scalp and hair improvement effect can be blended in an appropriate amount.
한편, 상기 두피 및 모발 개선 생약재 추출물을 함유하여 제조된 화장료 조성물은 화장수류, 로션류, 크림류, 샴푸류와 같은 다양한 제형으로 제조될 수 있으며, 구체적으로는 에멀젼상, 크림상, 페이스트상 등 다양한 성상으로 적용이 가능하고, 통상적인 화장료 제조법을 이용하여 제조할 수 있다. 특히, 전술한 두피 및 모발용 조성물은 두피 및 모발의 개선을 위한 화장료로서 이용되면 더욱 바람직하다.On the other hand, the cosmetic composition prepared by containing the scalp and hair improvement herbal medicine extract may be prepared in a variety of formulations, such as lotions, lotions, creams, shampoos, specifically, emulsion, cream, paste It can be applied in the form and can be prepared using a conventional cosmetic preparation method. In particular, the aforementioned scalp and hair composition is more preferably used as a cosmetic for improving the scalp and hair.
본 발명은 발모 및 탈모방지 효과, 양모효과, 항균효과, 가려움 방지효과, 두피 및 모발의 보습효과 등이 우수한 생약재 추출물 함유 조성물을 제공한다. 본 발명에 따른 조성물은 일반적인 두발용 조성물과 비교하여 발모 및 탈모방지 효과, 양모효과가 우수하고, 비듬균에 대한 항균 및 살균효과가 우수하며, 두피 및 모발에 적용 시 안전하며 우수한 사용감을 갖는 것으로 나타났다. 따라서 두피 및 모발개선에 대한 탁월한 효능을 갖으며, 피부자극이 없는 두피 및 모발용 제품, 특히 모발용 화장료 제품으로서 제품의 상용화나 상품성에서 탁월한 효과를 발휘할 수 있을 것으로 기대된다.The present invention provides an herbal extract-containing composition excellent in hair growth and hair loss prevention effect, wool effect, antibacterial effect, itching prevention effect, moisturizing effect of the scalp and hair. The composition according to the present invention has been shown to have excellent hair growth and hair loss prevention effect, wool effect, excellent antibacterial and bactericidal effect against dandruff, and safe and excellent feeling when applied to the scalp and hair compared to general hair composition. . Therefore, it has an excellent effect on scalp and hair improvement, and is expected to be able to exert an excellent effect on the commercialization or commercialization of the product as a product for scalp and hair without skin irritation, especially a hair cosmetic product.
이하, 본 발명을 구체적으로 설명하기 위해 실시예, 제형예 등의 구체적인 예를 들어 설명하기로 한다. 그러나 본 발명에 따른 실시예 또는 제형예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 아래에서 상술하는 예들에 한정되는 것으로 해석되지는 않는다. 본 발명에 따른 실시예 및 제형예들은 당 업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해서 제공되는 것에 불과하다.Hereinafter, specific examples such as examples, formulation examples, etc. will be described in order to specifically describe the present invention. However, embodiments or formulations according to the present invention can be modified in many different forms, the scope of the invention is not to be construed as limited to the examples described below. Examples and formulations according to the present invention are provided only to more fully explain the present invention to those skilled in the art.
<실시예 1 및 비교예 1~4> 두피 및 모발 개선 생약재 추출물의 제조<Example 1 and Comparative Examples 1 to 4> Preparation of the scalp and hair improvement herbal medicine extract
상기 생약재 추출물의 두피 및 모발 개선 효과를 측정하기 위하여 하기 표 1에 기재된 바와 같은 생약재 추출물을 제조하였다. 이때, 성분함량의 단위는 중량%이다. 각각의 조성물은 생약재 혼합물과 추출용매의 비가 1:5 비율로 혼합하였으며, 초음파추출 방법을 통하여 제조하였다. 비교예 1은 발모 및 탈모방지 효능을 갖는 것으로 분류한 약재군을, 비교예 2는 흰머리방지 효능을 갖는 것으로 분류한 약재군을, 비교예 3은 피부진정 효능을 갖는 것으로 분류한 약재군을, 비교예 4는 혈액순환 개선효능을 갖는 것으로 분류한 약재군을 추출하였으며, 실시예 1은 본 발명의 생약재 조성물로서 전체 약재를 혼합하여 추출하였다.In order to measure the scalp and hair improvement effect of the herbal extracts were prepared herbal extracts as described in Table 1 below. At this time, the unit of component content is weight%. Each composition was mixed in the ratio of the herbal mixture and the extraction solvent in a 1: 5 ratio, and prepared by the ultrasonic extraction method. Comparative Example 1 is a group of medicinal herbs classified as having hair growth and hair loss prevention effect, Comparative Example 2 is a group of medicinal herbs classified as having a baldness efficacy, Comparative Example 3 is a group of medicinal herbs classified as having a skin soothing effect, Comparative Example 4 extracted a group of medicinal herbs classified as having a blood circulation improving effect, Example 1 was extracted by mixing the whole medicinal herbs as a herbal composition of the present invention.
<실험예 1> 두피 및 모발 개선효과 동물시험Experimental Example 1 Scalp and Hair Improvement Effect Animal Test
두피 및 모발 개선효과의 측정은 C57BL 마우스를 이용한 발모촉진 평가시험, 마우스조직에서 모근세포의 생장촉진 평가시험 및 염증세포 발현 평가시험를 이용하여 측정하였다.The scalp and hair improvement effects were measured using a hair growth test using C57BL mice, a growth test of hair follicle cells in mouse tissues, and a test for inflammatory cell expression.
표 1에서 제조된 각각의 조성물에 대하여 각각 6마리의 마우스를 사용하였으며 측정에 사용된 C57BL 마우스는 등쪽 피부색이 분홍색을 보이는 휴지기 체모의 6주령을 사용하였으며 조심스럽게 쥐 등판의 털을 깎아내고, 깍은 부위에 붓을 사용하여 0.2 ml의 상기 실시예 및 비교예 시료를 각각 충분히 도포한 후 약 3분간 마사지를 한 다음 증류수로 충분히 헹구어 주었다. 시료처리는 매일 1회씩 실시하였으며, 마우스의 등에 털이 자라 완전히 덮은 상태인 2주 동안 각각 4일, 7일, 10일, 및 14일 경과 시에 발모촉진 상태를 관찰하였다.Six mice were used for each of the compositions prepared in Table 1, and the C57BL mice used for the measurements were 6 week old of resting hairs with pink dorsal skin color and carefully shaved, mowed 0.2 ml of the Example and Comparative Example samples were sufficiently applied to each silver site using a brush, and then massaged for about 3 minutes, followed by rinsing with distilled water. Sample treatment was performed once daily, and hair growth promoting conditions were observed at 4, 7, 10, and 14 days, respectively, for 2 weeks, when the hairs of the mice were completely covered with hair growth.
모낭세포 발현평가 및 염증세포 발현평가는 하기와 같이 진행하였다. 발모 촉진 평가시험 중 시험개시 후 7일 종료 시점에서 3마리, 시험 종료일에 3 마리씩 부검하였으며, 시료도포 부위를 해부하여 적출한 후 포르말린으로 고정하였다. 단계별로 알코올과 크실렌으로 탈수 처리한 후 파라핀으로 포매하고 조직절편기를 이용하여 5 μm의 절편을 만들어 다시 알코올과 크실렌으로 파라핀을 제거한 후, 모낭세포 발현평가는 시료를 H&E 염색하여 광학현미경으로 모낭조직의 조직학적 변화를 관찰하였으며, 염증세포 발현평가는 시료를 톨루이딘 블루 염색하여 광학현미경으로 염증세포(mast cell)의 조직학적 변화를 관찰하였다.Hair follicle expression evaluation and inflammatory cell expression evaluation was carried out as follows. During the hair growth promotion evaluation test, three animals were examined at the end of the 7 days after the start of the test and three at the end of the test, and the sample application sites were dissected and fixed with formalin. After dehydration with alcohol and xylene step by step, embedded with paraffin, 5 μm sections were made using a tissue slicer, paraffin was removed again with alcohol and xylene, and hair follicle expression was evaluated by H & E staining. Histologic changes were observed, and inflammatory cell expression was evaluated by toluidine blue staining and histological changes of inflammatory cells (mast cells) by light microscopy.
상기 시험의 결과 중 발모촉진 평가는 하기 표 2에 나타낸 평가기준에 준하여 평가하였으며, 모낭세포 발현평가 및 염증세포 발현평가는 광학현미경으로 관찰한 결과를 촬영한 사진으로 비교하였으며 하기 표 4에 나타낸 평가기준에 의하여 평가하였다. 발모촉진 평가의 결과는 하기 표 3과 도 1에 나타내었고 모낭세포 발현평가는 하기 표 5와 도 2에 나타내었으며, 염증세포 발현평가는 하기 표 6과 도 3에 나타내었다.Among the results of the test, hair growth promoting evaluation was evaluated according to the evaluation criteria shown in Table 2 below, hair follicle expression evaluation and inflammatory cell expression evaluation was compared with the photograph taken the results observed by optical microscope and the evaluation shown in Table 4 below Evaluation was made based on the criteria. The results of hair growth promoting evaluation are shown in Table 3 and FIG. 1, hair follicle expression evaluation is shown in Table 5 and FIG. 2, and inflammatory cell expression evaluation is shown in Table 6 and FIG. 3.
상기 표 3에서 나타낸 바와 같이, 시료를 도포한 후 7일 경과까지는 대부분의 시료에서 발모효과가 없는 것으로 나타났지만 10일 경과 후에는 실시예 1, 비교예 3, 및 비교예 4의 발모효과가 양호하게 나타남을 확인하였다. 또한 14일 경과 후에는 비교예 1을 제외하고 대부분의 시료의 발모효과가 우수하게 나타남을 확인하였으며, 특히 실시예 1 및 비교예 3의 경우는 발모효과가 매우 우수한 것으로 나타났다. 반면에 비교예 1의 경우 발모효과가 현저히 낮음은 물론 자극에 의한 홍반이 생성되는 것을 확인할 수 있었다. 발모효과가 있는 것으로 알려진 약재군인 비교예 1의 결과로서 발모효능과 더불어 피부 자극이 발모에 미치는 영향을 확인할 수 있었으며, 이러한 결과는 실시예 1의 결과로서 또한 확인할 수 있었다. 실시예 1의 경우 비교예 1에 포함된 약재가 포함되어 있었으나 전체 생약재 추출물로서는 피부자극이 동반되지 않았으며 이로 인해 발모에 저해효과를 주지 않은 것으로 사료된다. 실시예 1 및 비교예 1~4의 상기 발모효과는 도 1에서 나타낸 바와 같이 시험에 사용된 마우스의 사진을 통해서도 확인할 수 있다. 시료를 도포하지 않은 대조군에 비해 비교예 1을 제외한 나머지 시료의 생약재추출물의 발모효과가 우수함을 확인 할 수 있었다.As shown in Table 3, most of the samples showed no hair growth effect after 7 days of application of the sample, but after 10 days, the hair growth effects of Example 1, Comparative Example 3, and Comparative Example 4 were good. It appeared to appear. In addition, after 14 days, it was confirmed that most of the samples had excellent hair growth effects except for Comparative Example 1. In particular, in Example 1 and Comparative Example 3, the hair growth effect was very excellent. On the other hand, in Comparative Example 1 it was confirmed that the hair growth effect is significantly lower as well as erythema produced by the stimulation. As a result of Comparative Example 1, a group of medicinal herbs known to have a hair regrowth effect, it was possible to confirm the effect of skin stimulation on the hair growth along with the hair regrowth effect, and these results could also be confirmed as a result of Example 1. In the case of Example 1, the herbal medicines included in Comparative Example 1 were included, but the whole herbal extracts were not accompanied by skin irritation, and thus, did not inhibit the hair growth. The hair growth effect of Example 1 and Comparative Examples 1 to 4 can also be confirmed through a photograph of the mouse used for the test as shown in FIG. 1. It was confirmed that the hair growth effect of the herbal extracts of the remaining samples except Comparative Example 1 was superior to the control group did not apply the sample.
모낭세포 발현평가는 하기 표 5와 도 2에 나타낸 바와 같이, 발모효과 시험결과와 동일하게 비교예 1의 경우에는 피부자극에 의한 스트레스로 인하여 모근세포의 발달이 지연되는 것을 확인할 수 있었으며, 비교예 3의 경우 모낭세포가 부분적으로 발달함을 확인할 수 있었다. 특히, 본 발명의 생약재추출물인 실시예 1의 경우에 모낭 세포의 발달이 매우 우수하게 나타남을 확인할 수 있었다. 상기 발모효과 시험에서는 실시예 1과 비교예 3에서 유사하게 좋은 결과를 얻었지만, 모낭세포의 발현은 실시예 1을 도포한 마우스에서 가장 좋은 결과가 나타나는 것을 확인할 수 있었다. 모낭세포의 발현은 특히 모발성장의 근간이 되는 것으로서 모발성장 효과의 중요한 기준이 되는 결과라고 할 수 있다.As shown in Table 5 and Figure 2, hair follicle expression evaluation, in the case of Comparative Example 1 as in the hair growth effect test results, it was confirmed that the development of hair follicle cells is delayed due to stress caused by skin stimulation, Comparative Example In case of 3, hair follicle cells were partially developed. In particular, in the case of Example 1, the herbal extract of the present invention, it was confirmed that the development of hair follicle cells was very excellent. In the hair growth test, a good result was similarly obtained in Example 1 and Comparative Example 3, but it was confirmed that the expression of hair follicle cells showed the best result in the mouse coated with Example 1. The expression of hair follicle cells is the basis of hair growth, in particular, and can be said to be an important criterion for hair growth effects.
염증세포 발현평가는 피부자극이나 스트레스에 의하여 염증세포가 발현되는 정도를 비교하는 것으로서 표 6과 도 3에 나타낸 바와 같이, 피부자극 및 홍반이 심하게 나타났던 비교예 1의 경우 염증세포가 상대적으로 더 발현됨을 확인할 수 있었다.Inflammatory cell expression evaluation is to compare the degree of expression of inflammatory cells by skin irritation or stress, as shown in Table 6 and Figure 3, in the case of Comparative Example 1 in which severe skin irritation and erythema appeared severely more inflammatory cells Expression could be confirmed.
상기 실시예 1 및 비교예 1~4의 두피 및 모발 개선 동물시험의 결과, 모든 발모촉진 조성물에서 가장 중요한 사항은 자극 및 염증을 일으키지 않는 안전한 소재가 우선되어야 하며, 1차 모근세포의 성장과 2차 모발성장 촉진 소재의 적절한 배합이 발모촉진 효능을 더 크게 나타낼 것으로 사료되고, 본 발명에 따른 혼합 생약재 추출물인 실시예 1의 경우에 이러한 효능을 갖는 것을 확인하였다.As a result of the scalp and hair improvement animal test of Examples 1 and Comparative Examples 1 to 4, the most important matter in all hair promoting compositions should be a safe material that does not cause irritation and inflammation, and the primary hair root cell growth and 2 Proper formulation of the primary hair growth promoting material is expected to exhibit greater hair growth promoting effect, and it was confirmed that the mixed herbal medicine extract according to the present invention has the above-described effect.
<실험예 2> 항염효과 시험Experimental Example 2 Anti-inflammatory Effect Test
본 발명에서 제시한 두피 및 모발 개선 생약재 추출물의 항염효과를 측정하기 위하여 리폭시게나아제 저해효과를 측정하였다. 리폭시게나아제(5-lipoxygenase, 5-LO)는 각종 염증 및 알레르기성 질환에 관여하는 로이코트리엔 생합성의 첫 번째 반응에 작용하는 효소이다. 따라서 구조적 및 메카니즘적으로 5-LO와 유사한 SLO(soybean lipoxygenase)를 이용하여 리폭시게나아제의 저해효과를 측정하여 항염효과를 확인하였다. 리폭시게나아제 저해효과 측정과정은 하기와 같다. 1 mM 리놀레산 1 ml에 생약재추출물을 0.3, 1.3, 및 2.5% (v/v)의 농도로 첨가하고, 0.1 M의 인산나트륨 버퍼에 용해시킨 50,000 units/ml 리폭시게나아제 0.9 ml를 넣은 후, 25℃의 수욕상에서 15분간 반응시켰다. 20% (w/v) 트리클로로아세트산 0.5 ml를 넣어 반응을 종결시키고, 0.6% (w/v) TBA를 1 ml 넣은 후 끓는 물에서 15분간 발색시켰다. 그 후 얼음물에 2분간 냉침시키고, n-부탄올 2 ml를 넣고 진탕혼합한 후, 3,500 rpm으로 5분간 원심분리 하였다. 상층(n-부탄올층)을 취하여 535 nm에서 흡광도를 측정하여 항염효과(%)를 평가하였다. 대조군은 혼합 추출물 대신 용매를 사용하였다. 블랭크는 리폭시게나아제 대신 0.1 M 인산나트륨 버퍼를 사용하였다. 리폭시게나아제 저해 효과는 하기 수학식 1에 의하여 구하였으며 측정결과를 도 4에 나타내었다.In order to measure the anti-inflammatory effect of the scalp and hair improvement herbal extracts presented in the present invention, the lipoxygenase inhibitory effect was measured. 5-lipoxygenase (5-LO) is an enzyme that acts on the first reaction of leukotrienes biosynthesis involved in various inflammatory and allergic diseases. Therefore, the anti-inflammatory effect was confirmed by measuring the inhibitory effect of lipoxygenase using SLO (soybean lipoxygenase) similar to 5-LO structurally and mechanism. The procedure for measuring the inhibitory effect of lipoxygenase is as follows. To 1 ml of 1 mM linoleic acid, herbal extracts were added at concentrations of 0.3, 1.3, and 2.5% (v / v), and 0.9 ml of 50,000 units / ml lipoxygenase dissolved in 0.1 M sodium phosphate buffer was added. It was made to react for 15 minutes on the water bath of ° C. 0.5 ml of 20% (w / v) trichloroacetic acid was added to terminate the reaction, and 1 ml of 0.6% (w / v) TBA was added and developed in boiling water for 15 minutes. After cooling for 2 minutes in iced water, 2 ml of n-butanol was added and shake-mixed, and centrifuged for 5 minutes at 3,500 rpm. The anti-inflammatory effect (%) was evaluated by taking the upper layer (n-butanol layer) and measuring the absorbance at 535 nm. The control group used a solvent instead of the mixed extract. The blank used 0.1 M sodium phosphate buffer instead of lipoxygenase. The lipoxygenase inhibitory effect was calculated by the following Equation 1 and the measurement results are shown in FIG. 4.
본 발명에서 제공하는 두피 및 모발 개선 생약재 추출물의 항염효과는 도 4에 나타낸 바와 같이, 생약재 추출물의 농도 0.3%(v/v)에서 7.2%의 항염효과를 보였으며, 1.3%(v/v)에서 25.3%의 항염효과를 보였다. 또한, 50%의 리폭시게나아제 저해효과를 보이는 IC50 값의 경우에 생약재 추출물 2.5%(v/v)의 농도에서 확인함으로써 본 발명에서 제공하는 두피 및 모발 개선 생약재 추출물의 항염효과를 확인할 수 있었다.As shown in Figure 4, the anti-inflammatory effect of the scalp and hair improvement herbal medicine extract provided in the present invention showed an anti-inflammatory effect of 7.2% at a concentration of 0.3% (v / v) of the herbal medicine extract, 1.3% (v / v) Showed an anti-inflammatory effect of 25.3%. In addition, IC 50 with 50% lipoxygenase inhibitory effect In the case of value, the anti-inflammatory effect of the scalp and hair improvement herbal medicine extract provided by the present invention was confirmed by checking the concentration of the herbal extract 2.5% (v / v).
제형 Formulation 실시예Example 1 및 그 1 and its 비교예Comparative example 1 One
본 발명의 상기 두피 및 모발 개선 생약재 추출물을 포함하는 샴푸의 성분구성을 하기 표 7과 같이 구성하여 제조하였다. 이때, 성분함량의 단위는 중량%이다. 하기 표 7의 각 성분번호로 구별된 성분 중에서, 먼저 성분 11을 70℃의 온도에서 가열하고 다른 성분들을 가하여 균일하게 용해시킨 후, 성분 12를 가하여 교반하고 실온으로 냉각하여 제조하였다. 상기 제형 실시예 1에 대한 그 제형 비교예 1은 성분 12를 제외한 나머지 성분구성이나 제조방법은 동일하게 제조하였다.The composition of the shampoo comprising the scalp and hair improvement herbal medicine extract of the present invention was prepared by configuring as shown in Table 7. At this time, the unit of component content is weight%. Among the components identified by each component number in Table 7 below, component 11 was first heated at a temperature of 70 ° C., and the other components were added to dissolve uniformly. Then, component 12 was added thereto, stirred, and cooled to room temperature. The formulation of Comparative Example 1 for Formulation Example 1, except for the component 12, the composition of the other components or the preparation method was prepared in the same manner.
제형 Formulation 실시예Example 2~3 및 그 2-3 and its 비교예Comparative example 2 2
본 발명의 상기한 두피 및 모발 개선 생약재 추출물을 포함하는 크림류의 헤어트리트먼트의 성분구성을 하기 표 8과 같이 구성하여 제조하였다. 이때, 성분함량의 단위는 중량%이다. 하기 표 8의 각 성분번호로 구별된 성분 중에서 먼저 성분 1~5를 80℃의 온도에서 가열 용해시킨 다음, 성분 6~14를 가열용해하고 80℃로 조정하고 교반하면서 성분 1~5 혼합물과 혼합한 후, 호모믹서로 유화하였다. 이후, 상기 유화한 것을 30℃의 온도로 냉각한 후, 성분 13 및 14를 첨가하고 균일하게 될 때까지 교반하여 제조하였다. 상기 제형 실시예 2 및 3에 대한 그 제형 비교예 2는 성분 14를 제외한 나머지 성분구성이나 제조방법은 동일하게 제조하였다.The composition of the hair treatment of the creams including the scalp and hair improvement herbal medicine extract of the present invention was prepared as shown in Table 8. At this time, the unit of component content is weight%. Among the components identified by each component number in Table 8, components 1 to 5 were first dissolved by heating at a temperature of 80 ° C., and then components 6 to 14 were dissolved by heating, adjusted to 80 ° C., and mixed with the components 1 to 5 mixture with stirring. After emulsification with a homomixer. Thereafter, the emulsified product was cooled to a temperature of 30 ° C., and then components 13 and 14 were added and stirred until uniform. The formulation of Comparative Example 2 for Formulation Examples 2 and 3 except for component 14, the composition or preparation method was the same.
<실험예 3> 두피 및 모발 개선 화장료 조성물의 항균효과Experimental Example 3 Antimicrobial Effect of the Scalp and Hair Improvement Cosmetic Composition
본 발명에 따른 두피 및 모발 개선 화장료 조성물의 항균효과는 비듬균(Malassezia furfur , KCTC 7546)을 사용하여 평가하였으며 평가방법은 페이퍼 디스크 법을 적용하여 디스크 주위의 살균 범위인 클리어 존(clear zone)의 크기를 측정하는 방법으로서 평가하였다.Antibacterial effect of the scalp and hair improvement cosmetic composition according to the present invention is dandruff ( Malassezia furfur , KCTC 7546) was evaluated using the paper disk method to evaluate the size of the clear zone (clear zone) of the sterilization range around the disk.
상기 표 7에서 제조한 제형 실시예 1과 제형 비교예 1을 시료로 사용하였으며 대조군으로서 정제수를 사용하였다. 배양된 비듬균 액을 배지에 1/10로 희석하여 0.2 ml을 플레이트에 골고루 도포하여 잘 스며들게 한 후, 10 mm 크기의 페이퍼 디스크에 상기 제형 실시예 1과 비교예 1, 대조군인 물을 50 ul 점적하고 플레이트 중앙에 디스크를 심고 35℃에서 배양하며 상태를 관찰하였다. 상기 페이퍼 디스크에 시료를 도포한 후 그 결과를 비교하였다.Formulation Example 1 and Formulation Comparative Example 1 prepared in Table 7 were used as samples, and purified water was used as a control. After diluting the cultured dandruff by 1/10 to the medium, 0.2 ml is evenly applied to the plate and soaked well, and then 50 ul of water of Formulation Example 1 and Comparative Example 1, and the control water on a 10 mm size paper disk. The disc was planted in the center of the plate and incubated at 35 ° C to observe the condition. The sample was applied to the paper disk and the results were compared.
본 발명에서 제공하는 두피 및 모발 개선 화장료 조성물의 비듬균에 대한 항균효과는 도 5에 나타낸 바와 같이 대조군인 정제수 처리 시료에서는 클리어 존이 나타나지 않았고, 제형 비교예 1을 처리한 시료의 경우에는 클리어 존이 거의 형성되지 않았다. 반면에, 본 발명에서 제공하는 두피 및 모발 개선 화장료 조성물인 제형 실시예 1 시료를 처리한 경우에는 대략 30 mm의 클리어 존이 나타나는 것으로서 본 발명에서 제공하는 두피 및 모발개선 화장료 조성물의 비듬균에 대한 항균효과가 비교예에 비하여 월등히 우수함을 확인할 수 있었다.As shown in FIG. 5, the antimicrobial effect of the scalp and hair improvement cosmetic composition provided by the present invention on the dandruff was not clear zone in the purified water treated sample as a control, and in the case of the sample treated with Comparative Example 1, the clear zone was Hardly formed. On the other hand, the formulation of Example 1, which is a scalp and hair improvement cosmetic composition provided by the present invention, when a sample having a clear zone of about 30 mm appears, the antimicrobial activity of the scalp and hair improvement cosmetic composition provided by the present invention against dandruff. The effect was confirmed to be much superior to the comparative example.
<실험예 4> 두피 및 모발 개선 화장료 조성물의 양모효과Experimental Example 4 Wool Effect of Scalp and Hair Improvement Cosmetic Composition
본 발명에 따른 두피 및 모발개선 화장료 조성물의 양모효과는 모발의 건강상태를 측정하는 방법 중 하나인 모발 인장강도 측정법을 이용하여 평가하였다. 모발의 인장강도 측정은 모발에 서서히 힘을 가하여 그 때의 무게와 늘어남과의 관계를 모발의 단위면적으로 산출하며 건강한 모발의 경우, 신장률이 일정하고 파단중량도 큰 것으로 알려져 있다. The wool effect of the scalp and hair improvement cosmetic composition according to the present invention was evaluated by using the hair tensile strength measurement method, which is one of the methods for measuring the health of hair. The tensile strength of hair is measured by applying force to the hair and calculating the relationship between weight and extension at the unit area of hair.
상기 표 8에서 제조한 제형 실시예 2와 제형 비교예 2를 사용하였으며, 시료 모발로서 15세 정도의 여성 모발을 30 cm로 절취한 시료를 사용하여 Rheometer (Compac-100, Sun Science Co.)로 모발 인장강도를 측정하였다. 제형 실시예 2와 제형 비교예 2를 0.4 ml 취하여 시료 모발에 골고루 바른 후 1분간 마사지 하고 물로 충분히 헹군 다음, 헤어드라이기의 냉풍으로 모발을 건조하여 한 제형 당 10회 씩 모발의 인장강도를 측정하였다. 대조군으로 물을 사용하였다. 상기 과정을 1사이클(1일 1사이클)로 하며 총 3사이클을 반복하여 인장강도의 변화를 측정하였다.Formulation Example 2 and Formulation Comparative Example 2 prepared in Table 8 were used, and a sample hair cut at 30 cm of a female hair of about 15 years old was used as a sample hair by Rheometer (Compac-100, Sun Science Co.). Hair tensile strength was measured. 0.4 ml of Formulation Example 2 and Formulation Comparative Example 2 were evenly applied to the sample hair, then massaged for 1 minute, rinsed thoroughly with water, and the hair was dried by cold wind of hair dryer to measure the tensile strength of the hair 10 times per formulation. . Water was used as a control. The process was repeated one cycle (one cycle per day), and a total of three cycles were repeated to measure the change in tensile strength.
모발 인장강도 평가 결과는 도 6에 나타낸 바와 같이 본 발명에서 제공하는 두피 및 모발 개선 화장료 조성물인 제형 실시예 2의 경우 3사이클 후, 인장강도가 거의 일정하게 유지됨을 확인하였다. 제형 실시예 2를 도포한 경우 1사이클 후 파단중량은 136 g, 2사이클 후 파단중량은 136 g, 3사이클 후 파단중량은 140 g으로 거의 일정하게 유지되는 것을 확인하였다. 반면에, 비교예 2 및 대조군의 경우 인장강도가 서서히 감소함을 확인하였다. 물을 도포한 대조군의 경우 1사이클 후 파단중량은 137 g, 2사이클 후 파단중량은 127 g, 3사이클 후 파단중량은 123 g 으로 인장강도가 감소하였으며, 제형 비교예 2를 도포한 경우 1사이클 후 137 g, 2사이클 후 123 g, 3사이클 후 114 g 으로 크게 감소하는 것을 확인하였다. 모발용 제품 처리 후 인장강도가 유지되거나 증가하는 경우, 사용 된 시료의 양모효과가 양호한 것으로 판단할 수 있다. 반면에, 비교예 2나 대조군의 경우와 같이 모발에 시료를 처리한 후 인장강도가 감소하는 경우에는 모발의 손상도가 증가한 것으로 판단할 수 있다. 상기와 같이 모발의 인장강도 측정을 통하여 본 발명이 제공하는 두피 및 모발 개선 화장료 조성물의 양모효과가 양호한 것을 확인할 수 있었다.As a result of the evaluation of the tensile strength of the hair, as shown in FIG. 6, after 3 cycles in the case of Formulation Example 2, which is the scalp and the hair improvement cosmetic composition provided in the present invention, the tensile strength was confirmed to remain substantially constant. When Formulation Example 2 was applied, it was confirmed that the breaking weight after 1 cycle was 136 g, the breaking weight after 2 cycles was 136 g, and the breaking weight after 3 cycles was maintained at approximately constant 140 g. On the other hand, in Comparative Example 2 and the control it was confirmed that the tensile strength gradually decreased. In the case of the control group coated with water, the tensile strength was decreased to 137 g after 1 cycle, 127 g after 2 cycles, and 123 g after 3 cycles, and 1 cycle when the formulation of Comparative Example 2 was applied. After 137 g, after 2 cycles 123 g, after 3 cycles was confirmed to significantly decrease to 114 g. If the tensile strength is maintained or increased after the hair product treatment, the wool effect of the sample used may be judged to be good. On the other hand, when the tensile strength decreases after treating the sample as in the case of Comparative Example 2 or the control, it can be determined that the damage of the hair is increased. As described above, it was confirmed that the wool effect of the scalp and the hair improvement cosmetic composition provided by the present invention was good through the measurement of the tensile strength of the hair.
<실험예 5> 두피 및 모발 개선 화장료 조성물의 half-head testExperimental Example 5 Half-head Test of Scalp and Hair Improvement Cosmetic Composition
상기 두피 및 모발개선 생약재추출물을 함유하는 두피 및 모발개선 화장료 조성물의 사용감을 평가하기 위하여, 상기 표 8의 제형 실시예 2와 3, 및 그 비교예 2에서 제조된 헤어트리트먼트 화장료 조성물에 대하여 Half-head test (C. Robbins. Chemical and physical behavior of human hair, Von Nostrand Reinhold, New York, 102-110, 1979)를 실시하였다.In order to evaluate the usability of the scalp and hair improvement cosmetic composition containing the scalp and hair improvement herbal medicine extract, the hair treatment cosmetic composition prepared in Examples 2 and 3 of Table 8, and Comparative Example 2 Half A head test (C. Robbins. Chemical and physical behavior of human hair, Von Nostrand Reinhold, New York, 102-110, 1979) was performed.
25 내지 35세의 여성 20명을 대상으로 상기 제형 실시예 2 및 3과 그 비교예 2의 헤어트리트먼트 화장료 조성물을 일반적인 사용법에 따라 모발에 도포한 후, 기포성, 윤기, 매끄러움, 사용 시 촉감, 사용 후 촉감, 건조 후 촉감, 건조 후 빗질감에 대한 만족도를 평가하게 하였다. 이때 관능평가는 매우 우수(A, 5점), 우수(B, 3점), 보통(C, 0), 나쁨(D, -3점), 매우 나쁨(E, -5점)의 오점법 기준에 의거하여 수행하고 평가점수를 하기 수학식 2에 의하여 계산하였다. 평가결과는 하기 표 9에 나타내었다.After applying the hair treatment cosmetic composition of the formulations Examples 2 and 3 and Comparative Example 2 to the hair according to the general usage for 20 women aged 25 to 35 years, foaming, shine, smoothness, touch when using, Satisfaction with touch after use, touch after drying and combing after drying were evaluated. The sensory evaluation was based on the five-point method: very good (A, 5 points), good (B, 3 points), normal (C, 0), bad (D, -3 points), very bad (E, -5 points). Based on the calculation score was calculated by the following equation (2). The evaluation results are shown in Table 9 below.
상기 표 9에서 보는 바와 같이, 두피 및 모발 개선 생약재 추출물을 포함하는 화장료 조성물인 제형 실시예 2 및 3의 경우 상기 생약재 추출물을 포함하지 않는 제형 비교예 2에 비해 각각의 평가항목에 대한 만족도가 매우 우수하였으며, 이러한 결과는 두피 및 모발 개선 생약재 추출물이 피부진정효과, 양모효과, 보습효과 등에서 우수한 효과를 갖기 때문인 것으로 판단된다.As shown in Table 9, Formulation Examples 2 and 3, which is a cosmetic composition including the scalp and hair improvement herbal medicine extract, are very satisfied with each evaluation item compared to Comparative Formulation 2, which does not include the herbal medicine extract. This result is because the scalp and hair improvement herbal extracts have an excellent effect on skin soothing effect, wool effect, moisturizing effect and the like.
도 1은 본 발명의 일 실시예에 따른 두피 및 모발용 조성물의 발모효과를 보여주는 결과로서 C57BL 마우스를 이용한 발모시험 사진이다.1 is a photograph of the hair growth test using a C57BL mouse as a result showing the hair growth effect of the scalp and hair composition according to an embodiment of the present invention.
도 2는 본 발명의 일 실시예에 따른 두피 및 모발용 조성물의 모낭세포 발현효과를 보여주는 결과로서 C57BL 마우스를 이용한 발모시험에서 마우스 피부를 절취하여 염색처리한 후 광학현미경으로 촬영한 모낭세포의 사진이다.Figure 2 is a photograph of the hair follicle cells taken by optical microscopy after cutting and staining the mouse skin in the hair growth test using a C57BL mouse as a result showing the hair follicle cell expression effect of the scalp and hair composition according to an embodiment of the present invention. .
도 3은 본 발명의 일 실시예에 따른 두피 및 모발용 조성물의 염증세포 발현효과를 보여주는 결과로서 C57BL 마우스를 이용한 발모시험에서 마우스 피부를 절취하여 염색처리한 후 광학현미경으로 촬영한 염증세포의 사진이다.3 is a photograph of inflammatory cells taken with an optical microscope after cutting and staining mouse skin in a hair growth test using a C57BL mouse as a result showing the inflammatory cell expression effect of the scalp and hair composition according to an embodiment of the present invention. .
도 4는 본 발명의 일 실시예에 따른 두피 및 모발용 조성물의 항염효과를 보여주는 결과로서 생약재 추출물의 농도에 따른 리폭시게나아제 저해효과를 나타낸 도표이다.Figure 4 is a chart showing the lipoxygenase inhibitory effect according to the concentration of the herbal extracts as a result showing the anti-inflammatory effect of the scalp and hair composition according to an embodiment of the present invention.
도 5는 본 발명의 일 실시예에 따른 두피 및 모발용 생약재 추출물을 포함하는 화장료 조성물의 양모효과를 보여주는 도표로서 화장료 조성물을 처리한 모발의 인장강도를 나타낸 도표이다.Figure 5 is a diagram showing the tensile effect of the hair treated with the cosmetic composition as a diagram showing the effect of the wool composition of the cosmetic composition including the scalp and hair herbal extract according to an embodiment of the present invention.
도 6은 본 발명의 일 실시예에 따른 두피 및 모발용 생약재 추출물을 포함하는 화장료 조성물의 항균효과를 보여주는 결과로서 비듬균에 대한 항균력 시험 사진이다.Figure 6 is a photograph showing the antimicrobial activity against dandruff as a result showing the antimicrobial effect of the cosmetic composition comprising the herbal extract for scalp and hair according to an embodiment of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070106302A KR100822835B1 (en) | 2007-10-22 | 2007-10-22 | Plant extracts and cosmetic compositions for improvement of scalp and hair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070106302A KR100822835B1 (en) | 2007-10-22 | 2007-10-22 | Plant extracts and cosmetic compositions for improvement of scalp and hair |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100822835B1 true KR100822835B1 (en) | 2008-04-16 |
Family
ID=39571732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070106302A KR100822835B1 (en) | 2007-10-22 | 2007-10-22 | Plant extracts and cosmetic compositions for improvement of scalp and hair |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100822835B1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2943248A1 (en) * | 2009-03-17 | 2010-09-24 | Oreal | Cosmetic use of extract of wolfberry as agent for preventing and/or treating scalp disorders, preferably dandruff condition of scalp |
KR101032426B1 (en) | 2009-04-10 | 2011-05-03 | 박현정 | Shampoo composition containing oriental medicine and manufacturing method thereof |
KR101103651B1 (en) | 2011-02-01 | 2012-01-11 | 주식회사 예지미인 | Cosmetic composition the oriental medicine mixed extract preventing activity from hair loss |
KR101108710B1 (en) | 2010-10-28 | 2012-01-30 | (주)국심 | A cleanser and a manufacturing method therefor |
KR101160926B1 (en) * | 2011-04-29 | 2012-06-29 | 주식회사 사임당화장품 | A method of purifying herb medicine extracts and cosmetic compositions comprising thereof for preventing lose of hair and promoting growth of hair |
KR101206998B1 (en) * | 2012-03-21 | 2012-11-30 | 최한섭 | The scalp care composition for preventing depilation and improvement of hair growth and the hair products using the composition |
CN103432060A (en) * | 2013-08-30 | 2013-12-11 | 邱中乔 | Herbal anti-hair loss shampoo |
KR20140049797A (en) * | 2012-10-18 | 2014-04-28 | (주)아모레퍼시픽 | Cosmetic composition for activation of scalp blood circulation |
CN110354041A (en) * | 2019-08-20 | 2019-10-22 | 无限极(中国)有限公司 | Composition and its washing preparations containing the composition |
CN110354042A (en) * | 2019-08-20 | 2019-10-22 | 无限极(中国)有限公司 | Composition and its hair care formulations containing the composition |
CN110755330A (en) * | 2019-12-03 | 2020-02-07 | 浙江章华保健美发实业有限公司 | Compound pure natural hair dye and production method thereof |
KR20200099493A (en) * | 2019-02-14 | 2020-08-24 | 김창호 | Manufacturing method of natural oriental hair essence for preventing loss of hair |
CN113116778A (en) * | 2021-04-16 | 2021-07-16 | 广州中草世家化妆品有限公司 | Ginseng extracting solution and preparation method and application thereof |
WO2022055220A1 (en) * | 2020-09-08 | 2022-03-17 | 주식회사 종근당 | Composition for preventing or alleviating hair loss or hair damage, comprising mixed extract of leonurus japonicus houtt and corydalis remota |
CN115006468A (en) * | 2022-06-28 | 2022-09-06 | 西安外事学院 | Compound Chinese herbal medicine hair tonic and preparation method thereof |
CN115317412A (en) * | 2021-09-26 | 2022-11-11 | 郑州泽初生物科技有限公司 | Oil-control itching-relieving anti-dandruff shampoo and preparation method thereof |
CN115461036A (en) * | 2021-04-08 | 2022-12-09 | 芙蓝宝株式会社 | Cosmetic composition comprising aqueous solution of Olibanum for preventing alopecia and promoting hair growth |
KR20230039858A (en) | 2021-09-14 | 2023-03-22 | (주)와이제이비앤 | Cosmetic composition for improving damaged hair and head skin |
KR20230147899A (en) | 2022-04-15 | 2023-10-24 | (주)동구밭 | Cosmetic composition for reducing scalp oil and deodorizing the scalp |
KR20230149648A (en) | 2022-04-20 | 2023-10-27 | 주식회사 헤아 | Cosmetic composition for relieving itching on the scalp and moisturizing the scalp |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030033225A (en) * | 2001-10-19 | 2003-05-01 | 주식회사 태평양 | Composition for improving conditions of scalp and hair |
KR20070016002A (en) * | 2005-08-02 | 2007-02-07 | 박민식 | The cosmetic composition with a herb medicine extract and the producing method thereof |
KR20070098228A (en) * | 2006-03-31 | 2007-10-05 | 주식회사 한생화장품 | Cosmetic composition comprising herbal extracts for inhibiting scalp trouble |
-
2007
- 2007-10-22 KR KR1020070106302A patent/KR100822835B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030033225A (en) * | 2001-10-19 | 2003-05-01 | 주식회사 태평양 | Composition for improving conditions of scalp and hair |
KR20070016002A (en) * | 2005-08-02 | 2007-02-07 | 박민식 | The cosmetic composition with a herb medicine extract and the producing method thereof |
KR20070098228A (en) * | 2006-03-31 | 2007-10-05 | 주식회사 한생화장품 | Cosmetic composition comprising herbal extracts for inhibiting scalp trouble |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2943248A1 (en) * | 2009-03-17 | 2010-09-24 | Oreal | Cosmetic use of extract of wolfberry as agent for preventing and/or treating scalp disorders, preferably dandruff condition of scalp |
KR101032426B1 (en) | 2009-04-10 | 2011-05-03 | 박현정 | Shampoo composition containing oriental medicine and manufacturing method thereof |
KR101108710B1 (en) | 2010-10-28 | 2012-01-30 | (주)국심 | A cleanser and a manufacturing method therefor |
KR101103651B1 (en) | 2011-02-01 | 2012-01-11 | 주식회사 예지미인 | Cosmetic composition the oriental medicine mixed extract preventing activity from hair loss |
KR101160926B1 (en) * | 2011-04-29 | 2012-06-29 | 주식회사 사임당화장품 | A method of purifying herb medicine extracts and cosmetic compositions comprising thereof for preventing lose of hair and promoting growth of hair |
KR101206998B1 (en) * | 2012-03-21 | 2012-11-30 | 최한섭 | The scalp care composition for preventing depilation and improvement of hair growth and the hair products using the composition |
KR102055565B1 (en) * | 2012-10-18 | 2019-12-13 | (주)아모레퍼시픽 | Cosmetic composition for activation of scalp blood circulation |
KR20140049797A (en) * | 2012-10-18 | 2014-04-28 | (주)아모레퍼시픽 | Cosmetic composition for activation of scalp blood circulation |
CN103432060A (en) * | 2013-08-30 | 2013-12-11 | 邱中乔 | Herbal anti-hair loss shampoo |
KR20200099493A (en) * | 2019-02-14 | 2020-08-24 | 김창호 | Manufacturing method of natural oriental hair essence for preventing loss of hair |
KR102274948B1 (en) | 2019-02-14 | 2021-07-08 | 김창호 | Manufacturing method of natural oriental hair essence for preventing loss of hair |
CN110354041A (en) * | 2019-08-20 | 2019-10-22 | 无限极(中国)有限公司 | Composition and its washing preparations containing the composition |
CN110354042A (en) * | 2019-08-20 | 2019-10-22 | 无限极(中国)有限公司 | Composition and its hair care formulations containing the composition |
CN110755330A (en) * | 2019-12-03 | 2020-02-07 | 浙江章华保健美发实业有限公司 | Compound pure natural hair dye and production method thereof |
WO2022055220A1 (en) * | 2020-09-08 | 2022-03-17 | 주식회사 종근당 | Composition for preventing or alleviating hair loss or hair damage, comprising mixed extract of leonurus japonicus houtt and corydalis remota |
CN115461036A (en) * | 2021-04-08 | 2022-12-09 | 芙蓝宝株式会社 | Cosmetic composition comprising aqueous solution of Olibanum for preventing alopecia and promoting hair growth |
CN115461036B (en) * | 2021-04-08 | 2024-03-05 | 芙蓝宝株式会社 | Cosmetic composition for preventing alopecia and promoting hair growth comprising aqueous solution of Olibanum |
CN113116778A (en) * | 2021-04-16 | 2021-07-16 | 广州中草世家化妆品有限公司 | Ginseng extracting solution and preparation method and application thereof |
KR20230039858A (en) | 2021-09-14 | 2023-03-22 | (주)와이제이비앤 | Cosmetic composition for improving damaged hair and head skin |
CN115317412A (en) * | 2021-09-26 | 2022-11-11 | 郑州泽初生物科技有限公司 | Oil-control itching-relieving anti-dandruff shampoo and preparation method thereof |
KR20230147899A (en) | 2022-04-15 | 2023-10-24 | (주)동구밭 | Cosmetic composition for reducing scalp oil and deodorizing the scalp |
KR20230149648A (en) | 2022-04-20 | 2023-10-27 | 주식회사 헤아 | Cosmetic composition for relieving itching on the scalp and moisturizing the scalp |
CN115006468B (en) * | 2022-06-28 | 2023-06-06 | 西安外事学院 | Compound Chinese herbal medicine hair-growing liquid and preparation method thereof |
CN115006468A (en) * | 2022-06-28 | 2022-09-06 | 西安外事学院 | Compound Chinese herbal medicine hair tonic and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100822835B1 (en) | Plant extracts and cosmetic compositions for improvement of scalp and hair | |
KR101509608B1 (en) | Composition for improving scalp and hair condition | |
CN106691902A (en) | Composition containing ampelopsis and acacia extract and use method of composition | |
US9554985B2 (en) | Agent for promoting hair growth and method for preparing same | |
JP2643986B2 (en) | Head cosmetics | |
KR20090005479A (en) | Composition for promoting hair growth | |
JPH0930931A (en) | Cosmetic | |
CN106214592A (en) | Hair follicle nutrient liquor composition and preparation method thereof | |
CN107530258A (en) | For promoting hair growth or hair reparation and composition for anti-inflammatory | |
JP2003261432A (en) | Skin care preparation | |
CN112870333A (en) | Composition and preparation for improving alopecia and promoting hair growth of human, and preparation method and application thereof | |
JP5039266B2 (en) | Ceramide production promoter | |
KR101516536B1 (en) | Composition for Preventing Hair Loss and Promoting Hair Growth and A method for manufacturing thereof | |
CN109260121B (en) | Raw material formula for preventing hair loss and growing hair | |
KR100702327B1 (en) | Cosmetic material including extract of camellia flower for skin abirritation | |
JP2005504088A (en) | Cosmetic composition for caring for male skin and hair | |
KR102030275B1 (en) | Hair cleanser composition | |
JP2003212749A (en) | INHIBITOR OF AGEs FORMATION AND SKIN CARE PREPARATION COMPRISING THE SAME | |
Barve et al. | The Chemistry and Applications of Sustainable Natural Hair Products | |
Deshmukh et al. | A Comprehensive Review Article on Herbal Cosmetics | |
KR101807577B1 (en) | Traditional oriental medicine shampoo composition and manufacturing method thereof) | |
KR101830864B1 (en) | Cosmetic composition for inhibiting hair loss and enhanching hair growth | |
TW201517929A (en) | Methods and compositions for enhancing hair quality using blackberry extract | |
JP2003261417A (en) | Skin care preparation | |
KR20050102346A (en) | Hair growth agent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130207 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140318 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160405 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170405 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180410 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190328 Year of fee payment: 12 |